|

GSK5784283 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • GlaxoSmithKline2

Indications

  • Pulmonary Disease, Chronic Obstructive1
  • Asthma1
  • COPD1

Doral, Florida1 trial

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

GSK Investigational Site

Phase 3

Austin, Texas1 trial

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

GSK Investigational Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.